Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While MOTS-c improves insulin sensitivity, enhances glycolysis, reduces oxidative stress, and shows protective effects in models of metabolic syndrome, aging, and ischemia-reperfusion injury8135146, Thymosin Alpha-1 is clinically used in some countries as an immunomodulator for chronic hepatitis B/C and as an adjuvant in cancer therapy, enhancing cell-mediated immunity41487.
While MOTS-c works as a 16-amino-acid mitochondrial-derived peptide that translocates to the nucleus under metabolic stress and regulates glucose and lipid metabolism largely via activation of AMPK and modulation of mTOR and folate-cycle–linked pathways854140146, Thymosin Alpha-1 is a 28-amino-acid thymic peptide fragment of prothymosin alpha that activates dendritic cells and T cells primarily via TLR9/MyD88/NF-κB signaling, enhancing Th1 responses and NK-cell cytotoxicity414.
MOTS-c
Thymosin Alpha-1
Toll-like receptors, predominantly TLR9 (and also TLR2/TLR3) on plasmacytoid dendritic cells and other immune cells4
MOTS-c
MT-RNR1
Thymosin Alpha-1
PTMA
MOTS-c and Thymosin Alpha-1 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: MOTS-c is more often discussed in the realm of Metabolic and endocrine and Aging and longevity, whereas Thymosin Alpha-1 is more often associated with the realm of Immunology and inflammation and Oncology. They also influence different molecular systems, with MOTS-c tracking more closely to Mitochondrial membrane while Thymosin Alpha-1 centers more on Toll-like receptor. MOTS-c has a more mitochondrial-encoded origin, while Thymosin Alpha-1 is closer to natural endogenous background and their development context also differs, with MOTS-c in Preclinical development while Thymosin Alpha-1 is approved. Thymosin Alpha-1 incorporates acetylation features that are not part of MOTS-c, while their sequence patterns also diverge, with MOTS-c showing hydrophobic domain features and Thymosin Alpha-1 showing protein-mimetic sequence features.
No related articles are linked to these peptides yet.